about
Endocrine Risk Factors for Cognitive ImpairmentEpicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance.Postprandial Triglyceride Is Associated with Fasting Triglyceride and HOMA-IR in Korean Subjects with Type 2 Diabetes.Multiple endocrine neoplasia type 1 with multiple leiomyomas linked to a novel mutation in the MEN1 geneLong-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study.The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008-2010).Thyroid "atypia of undetermined significance" with nuclear atypia has high rates of malignancy and BRAF mutation.Lower-but-normal serum TSH level is associated with the development or progression of cognitive impairment in elderly: Korean Longitudinal Study on Health and Aging (KLoSHA).The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance.Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia.Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease.Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model.Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment.Counterintuitive relationship between visceral fat and all-cause mortality in an elderly Asian population.Clinical Feasibility of Continuously Monitored Data for Heart Rate, Physical Activity, and Sleeping by Wearable Activity Trackers in Patients with Thyrotoxicosis: Protocol for a Prospective Longitudinal Observational Study.Validity and Reliability of the Korean Version of the Hyperthyroidism Symptom Scale.Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).Star-Shaped Intense Uptake of ¹³¹I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq.Clinical Feasibility of Monitoring Resting Heart Rate Using a Wearable Activity Tracker in Patients With Thyrotoxicosis: Prospective Longitudinal Observational StudyEffect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapyDigital Medicine in Thyroidology: A New Era of Managing Thyroid Disease
P50
Q26749493-5A5D3394-815C-47B4-B1DE-6A2AF84D91F9Q30462758-977342AB-5600-497F-9E30-C8ECC0DF8BB6Q35228225-4B756DEF-52EC-4A6C-9032-C841DBA0E70EQ37040923-CEE2956A-2B33-4F6B-96F2-590115E10338Q37587879-73982709-D7EF-4268-9384-CBEB9D46C24BQ38433832-47B79439-60AA-49F6-97A8-4C2E5DA45F28Q38434484-6B079943-F7B0-4C5D-AE04-0E8928E7C19CQ38436182-D47B9CDF-6BAC-4398-87DC-00D996FD26EAQ38439836-D40A8A84-BADB-494E-BD79-6B4E7B0807CBQ38440620-422C122C-6645-46BB-8A7A-01294CA3B02FQ38444141-022FE555-EFAE-46FB-84CD-B824A73F4EDBQ38445993-DC257446-A45E-4EB4-9F25-E3744E97F985Q38446180-07AAB161-53FF-42B1-A58F-E52B293FAC0AQ38453440-470B60E7-3E7F-4477-B425-7645A5D60402Q38459547-B75BAB70-06F5-4565-80B3-680B0464548FQ38461943-7B6C3FEE-B951-42A8-8A4F-2574B58CB23AQ38468253-075B4078-E547-4A47-BDFC-B88BE45941E5Q38480622-7E6B477F-1EFF-4A7D-8A96-9638CE4D480EQ38489233-6399E38B-E5C0-4F34-8AF9-C0A787889A53Q44051667-B47DC9C6-B1B0-44BB-8244-9BEBEAA9D906Q53082229-7E9EBF5C-E89F-426C-A774-E256340E8220Q54977606-B388A27E-3B73-442D-BF2E-D70387E83496Q55412973-6FD7D485-FE4B-4483-B363-C81A9900E950Q55422207-F1A12739-9D7D-4694-BB3B-ADC59F231446Q57724080-7B994215-5971-4DCB-A720-FB8462BE0DF8Q91862534-85653F3B-A074-41F8-8372-AE63B6FC1735Q93142186-2F363029-DEFB-4455-A4E8-749CAC975AD0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jae Hoon Moon
@ast
Jae Hoon Moon
@en
Jae Hoon Moon
@es
Jae Hoon Moon
@nl
type
label
Jae Hoon Moon
@ast
Jae Hoon Moon
@en
Jae Hoon Moon
@es
Jae Hoon Moon
@nl
prefLabel
Jae Hoon Moon
@ast
Jae Hoon Moon
@en
Jae Hoon Moon
@es
Jae Hoon Moon
@nl
P106
P1153
35307382100
P31
P496
0000-0001-6327-0575